Dr. Eduardo Abeliuk, the Chairman and CEO at TeselaGen Biotech, a Silicon Valley based company that works at the interface between Biotechnology, Artificial Intelligence and Enterprise Software joins Enterprise Radio.
Listen to host Eric Dye & guest Dr. Eduardo Abeliuk discuss the following:
You are the founder & CEO of Teselagen – tell us about the company and its mission.
What motivated you to pursue a career in biotech?
What are some of the current trends we are seeing in biotech today?
What are some of the major applications that Teselagen is being used for?”
Tell us about the digitalization of biotech.
Tell us 3 major wishes you have for biotech advancements and how it will affect our daily lives?
Dr. Eduardo Abeliuk is a U.S. based entrepreneur and technologist with over twenty years of experience driving technology development and innovation at various high-tech companies in the US. He is currently the Chairman and CEO at TeselaGen Biotech., a Silicon Valley based company that works at the interface between Biotechnology, Artificial Intelligence and Enterprise Software. Dr. Abeliuk holds a double bachelor’s degree in Physics and in Electrical Engineering from University of Chile, a M.S. in Bioengineering and a Ph.D. in Electrical Engineering from Stanford University. His academic work has been published by prestigious journals and he holds multiple U.S. patents on computational biology and AI.
People also listened to this: Bastille’s Wireless Threat Intelligence Platform Makes Invisible Connections And Threats Visible
The post Teselagen’s AI Enabled Operating System for Biotechnology appeared first on Enterprise Podcast Network – EPN.